Clinical evidence on RefluG™ ISOREPAIR: new brochure available

Giellepi is glad to announce the new brochure with the latest clinical evidence on RefluG™ Isorepair, the new barrier therapy for gastroesophageal reflux.

Download the new RefluG™ ISOREPAIR brochure !

RefluG™ Isorepair is an innovative substance-based medical device class IIa designed to reduce gastroesophageal reflux symptoms through a topical protectant and regenerative effect of the esophageal mucosa.

With the double-blind, placebo-controlled, randomized clinical trial (Ribaldone et al., 2020), RefluG™ Isorepair confirms to be safe and efficient in fast symptoms reduction.

RefluG™ Isorepairis a liquid gel indicated for the treatment of common GERD symptoms including heartburn, regurgitation, retrosternal pain, difficulty of swallowing, chronic cough, and acid taste. It provides mucosal protection against acid and pepsin, supporting the physiological reparative mechanism of the gastroesophageal mucosa.

Download the new RefluG™ ISOREPAIR brochure updated with clinical data.


Rimani aggiornato sulle novità

* campi obbligatori